BlueWhale Bio
BlueWhale Bio is dedicated to accelerating the growth and adoption of cell-based therapies. The company aims to address critical shortcomings in current treatment paradigms by developing a portfolio of groundbreaking products that make cell therapy more accessible, faster, and cost-effective. Inspired by whales as ecosystem engineers, BlueWhale Bio aspires to be a vital part of the cell therapy innovation ecosystem, re-engineering how cell therapies are manufactured.
Industries
Nr. of Employees
small (1-50)
BlueWhale Bio
Products
Portfolio of cell-based therapies and enabling manufacturing technologies (in development)
A pipeline of products and platform technologies under development aimed at broadening access to cell therapies by addressing manufacturing and performance limitations.
Portfolio of cell-based therapies and enabling manufacturing technologies (in development)
A pipeline of products and platform technologies under development aimed at broadening access to cell therapies by addressing manufacturing and performance limitations.
Services
Development of enabling platform technologies to support next-generation cell and gene therapies and improve manufacturability.
Development of enabling platform technologies to support next-generation cell and gene therapies and improve manufacturability.
Expertise Areas
- Cell therapy manufacturing
- Platform development for cell and gene therapies
- Immunotherapy and engineered cell research
- Process optimization and scale-up for biologics
Key Technologies
- Cell and gene therapy platforms
- Engineered immune cell therapies
- Cell manufacturing process technologies
- Platform technologies to improve therapy durability and efficacy